Ancillary Advantage, Inc.

Ancillary Advantage, Inc.

Ancillary Advantage, Inc.

Overview
Date Founded

1999

Headquarters

1255 West 15th Street,Suite 540,Plano, TX 75075-7248

Type of Company

Private

Industries

Medical Products & Equipment
Hospitals & Patient Services
Holding Companies
Wholesale: Medical Supplies & Pharmaceuticals
Retail: Drug Stores

Company Description

Ancillary Advantage, Inc. specializes in orthopaedic bracings provider. Its solutions offers staffing, product sourcing, revenue management, program management, and myAncillary. The company was founded in 1999 and is headquartered in Plano, TX.

Contact Data
Trying to get in touch with decision makers at Ancillary Advantage, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Director

DME Coordinator

DME Coordinator

Vice President-Finance & Administration

Vice President, Operations

Area Manager

Reimbursement Manager

Board of Directors

Co-Founder & Partner at Ferrer Freeman & Co. LLC

Former President & Chief Executive Officer at CAS Medical Systems Inc.

Chairman, President & Chief Executive Officer at Concentra Operating Corp.

Founding Partner at Peloton Equity LLC

Chief Executive Officer & Director at Ancillary Advantage, Inc.

Paths to Ancillary Advantage, Inc.
Potential Connections via
Relationship Science
You
Ancillary Advantage, Inc.
Investors
Details Hidden

Ferrer Freeman & Co. (FFC) invests exclusively in growth-stage healthcare and healthcare-related companies, including healthcare services, clinical products and outsourcing/infrastructure. They invest from $15 million to $45 million in equity per company for growth capital, buildups and select buyouts. Growth capital is used to fund acquisitions, product commercialization, geographical expansion or facility expansion. FFC usually invests growth capital in private companies, but will occasionally provide growth capital to public companies as well. Buildup capital supports a business plan which does not usually have an existing operating business. FFC and management usually agree on a plan that requires the measured use of capital over time to build new operations, acquire smaller companies or some combination of both. The firm participates in buyout transactions when they believe they have unique insight into the target company or its management team.FFC invests in the appropriate security to match the risk of the investment, the future capital needs of the business and the requirements of management and existing investors. This includes equity and quasi-equity securities such as common stock, convertible preferred stock and convertible subordinated debt. FCC usually serves as the sole institutional investor or as part of an investment group. They typically take at least one seat on their portfolio companies' board of directors and take an active role in board activities.

Details Hidden

Orthofix International NV engages in the research, development, and market of orthopedic solutions. It operates through the following business segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment produces and sells devices for bone fusion enhancement in cervical and lumbar spine through the pulsed electromagnetic technology. The Biologics segment includes regenerative products. The Extremity Fixation segment manufactures and distributes orthopedic products for fracture repair, deformity correction, and bone reconstruction. The Spine Fixation segment develops and sells implant products for spine surgeries. The company was founded on October 19, 1987 and is headquartered in Willemstad, Netherlands.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ancillary Advantage, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ancillary Advantage, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Ancillary Advantage, Inc..